Literature DB >> 6201213

Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells.

J H Falkenburg, J Jansen, N van der Vaart-Duinkerken, W F Veenhof, J Blotkamp, H M Goselink, J Parlevliet, J J van Rood.   

Abstract

The expression of monomorphic Ia-like antigens and polymorphic (allotypic) HLA-DR determinants on CFU-GM, BFU-E, CFU-E, and CFU-GEMM was studied in bone marrow and peripheral blood cells from normal healthy individuals. Using various polyclonal and monoclonal anti-Ia-like antibodies, the presence of HLA-DR backbone antigens was shown on all hematopoietic progenitor cells (HPC) studied, both in complement-dependent cytotoxicity assays and in fluorescence-activated cell sorting (FACS). The expression of allotypic determinants was demonstrated on all HPCs, using the HLA-DR typing sera anti-HLA-DR1, 2, 3, 4, 5, and 7. The Class II antigen MT-2 was also shown on all HPCs, using both monoclonal and alloantisera, whereas the MB-1 (DC-1) determinant could not be demonstrated on HPCs. This might open the possibility of removing MB-1-positive malignant cells from the graft in autologous bone marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201213

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  HLA-class II antigens on human hematopoietic progenitors.

Authors:  F W Busch; M Langer; G Pawelec; A Ziegler; P Wernet; H J Bühring; P Meyer; C Müller
Journal:  Blut       Date:  1987-03

Review 2.  Phenotypic and genotypic characteristics of the human prothymocyte.

Authors:  J J van Dongen; W M Comans-Bitter
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

Review 3.  Graft versus host diseases: new versions of old problems?

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-02

4.  Tolerance to solid organ transplants through transfer of MHC class II genes.

Authors:  K C Sonntag; D W Emery; A Yasumoto; G Haller; S Germana; T Sablinski; A Shimizu; K Yamada; H Shimada; S Arn; D H Sachs; C LeGuern
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W E Fibbe; W F Veenhof; A Brand; J H Falkenburg
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W F Veenhof; M Hamilton; W E Fibbe; J J Van Rood; J H Falkenburg
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

8.  CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.

Authors:  Peter van Balen; Cornelis A M van Bergen; Simone A P van Luxemburg-Heijs; Wendy de Klerk; Esther H M van Egmond; Sabrina A J Veld; Constantijn J M Halkes; Jaap-Jan Zwaginga; Marieke Griffioen; Inge Jedema; J H Frederik Falkenburg
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

9.  Human hematopoietic progenitor cells in long-term cultures express HLA-DR antigens and lack HLA-DQ antigens.

Authors:  J H Falkenburg; W E Fibbe; H M Goselink; J J Van Rood; J Jansen
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

Review 10.  Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sarah Morin-Zorman; Pascale Loiseau; Jean-Luc Taupin; Sophie Caillat-Zucman
Journal:  Front Immunol       Date:  2016-08-12       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.